Group One Trading, L.P. Bio Xcel Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.54 Billion
Q4 2024

A detailed history of Group One Trading, L.P. transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 18,116 shares of BTAI stock, worth $38,587. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,116

Previous 30,162 39.94%

Holding current value

$38,587

Previous $18,000 66.67%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.32 - $0.73 $3,854 - $8,793	-12,046 Reduced 39.94%	18,116 $6,000
Q3 2024 Nov 14, 2024	BUY	$0.53 - $1.34 $15,985 - $40,417	30,162 New	30,162 $18,000
Q3 2023 Nov 09, 2023	BUY	$2.49 - $11.85 $95,984 - $456,793	38,548 New	38,548 $97,000
Q1 2023 May 12, 2023	SELL	$17.7 - $33.24 $527,778 - $991,150	-29,818 Reduced 98.71%	390 $7,000
Q4 2022 Feb 09, 2023	BUY	$10.25 - $22.43 $309,632 - $677,565	30,208 New	30,208 $648,000
Q2 2022 Aug 11, 2022	SELL	$9.03 - $21.55 $44,653 - $106,564	-4,945 Reduced 50.54%	4,840 $64,000
Q1 2022 May 12, 2022	BUY	$15.0 - $22.83 $84,375 - $128,418	5,625 Added 135.22%	9,785 $205,000
Q4 2021 Feb 11, 2022	SELL	$20.12 - $35.09 $156,553 - $273,035	-7,781 Reduced 65.16%	4,160 $85,000
Q3 2021 Nov 12, 2021	SELL	$23.84 - $32.03 $39,002 - $52,401	-1,636 Reduced 12.05%	11,941 $362,000
Q2 2021 Aug 10, 2021	SELL	$29.06 - $38.83 $124,928 - $166,930	-4,299 Reduced 24.05%	13,577 $395,000
Q1 2021 May 12, 2021	SELL	$39.04 - $64.6 $50,752 - $83,979	-1,300 Reduced 6.78%	17,876 $772,000
Q4 2020 Feb 10, 2021	SELL	$42.46 - $56.58 $427,444 - $569,590	-10,067 Reduced 34.43%	19,176 $886,000
Q3 2020 Nov 12, 2020	BUY	$37.44 - $64.63 $175,144 - $302,339	4,678 Added 19.04%	29,243 $1.27 Million
Q2 2020 Aug 13, 2020	SELL	$17.62 - $58.71 $201,167 - $670,292	-11,417 Reduced 31.73%	24,565 $1.3 Million
Q1 2020 May 13, 2020	BUY	$12.26 - $41.14 $441,139 - $1.48 Million	35,982 New	35,982 $804,000

Others Institutions Holding BTAI

# of Institutions

Shares Held

8.63M

Call Options Held

34.5K

Put Options Held

59.4K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $59.7M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Bio Xcel Therapeutics, Inc. Transaction History